Zingale Anna, Carrera Paola, Lazzarin Adriano, Scarpellini Paolo
Infectious Diseases Division. Clinical Molecular Biology, San Raffaele Scientific Institute, Milan, Italy.
J Clin Microbiol. 2003 Jun;41(6):2709-12. doi: 10.1128/JCM.41.6.2709-2712.2003.
One hundred ninety-four bronchoalveolar specimens were evaluated by microscopic examination and by amplification of a sequence of a Pneumocystis carinii dihidropteroate synthase gene for identification of mutations linked to sulfa resistance. PCR sensitivity and specificity were 100 and 86.7%, respectively, compared to results of microscopic examination. However, 7 out of 19 microscopy-negative, PCR-positive samples were collected from subjects with a clinically high probability of P. carinii pneumonia, suggesting that PCR may be more sensitive than microscopic examination, although the absolute performance of PCR cannot be determined. Mutations were identified in 28 out of 70 (40%) PCR-positive specimens and were significantly more common in patients exposed to sulfa drugs (21 out of 29 [72.4%]) than in those not exposed to sulfa drugs (4 out of 35 [11.4%]).
对194份支气管肺泡标本进行了显微镜检查,并通过扩增卡氏肺孢子虫二氢蝶酸合酶基因序列来鉴定与磺胺耐药相关的突变。与显微镜检查结果相比,PCR的敏感性和特异性分别为100%和86.7%。然而,在19份显微镜检查阴性但PCR阳性的样本中,有7份是从临床高度怀疑患有卡氏肺孢子虫肺炎的受试者中采集的,这表明PCR可能比显微镜检查更敏感,尽管无法确定PCR的绝对性能。在70份PCR阳性标本中有28份(40%)检测到突变,在接触过磺胺类药物的患者中(29份中有21份[72.4%])比未接触过磺胺类药物的患者中(35份中有4份[11.4%])更为常见。